HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (4) Citing Articles via Google Scholar Google Scholar Articles by Decaestecker, K. Articles by De Boeck, K. Search for Related Content PubMed PubMed Citation Articles by Decaestecker, K. Articles by De Boeck, K.

Genotype/phenotype correlation of the G85E mutation in a large cohort of cystic fibrosis patients

¹ Dept of Pediatrics, ² Laboratory of Aquatic Ecology, and ³ Dept for Human Genetics, University of Leuven, Leuven, Belgium. ⁴ Ospedale Civile Maggiore, Verona, Italy

CORRESPONDENCE: K. De Boeck, University of Leuven, Cystic Fibrosis Center of Leuven, Herestraat 49, B-3000, Leuven, Belgium. Fax: 32 16343842. E-mail: christiane.deboeck@uz.kuleuven.ac.be

Keywords: Cystic fibrosis, cystic fibrosis transmembrane conductance regulator, G85E mutation, genotype-phenotype, mutation

Received: February 10, 2003
Accepted January 22, 2004

In this European study, the phenotype in 68 patients, homozygous or compound heterozygous for the G85E mutation, was investigated.

Each index case was compared with two cystic fibrosis (CF) patients from the same clinic, matched for age and sex: one with pancreatic sufficiency (PS) and one with pancreatic insufficiency (PI).

When comparing 31 G85E/F508del and F508del/F508del patients, there were no differences in median age at diagnosis, mean sweat chloride value, most recent weight for height, most recent forced expiratory volume in one second % predicted, prevalence of chronic Pseudomonas aeruginosa colonisation and typical CF complications. However, PI was less frequent in the G85E/F508del group. Comparison of 55 G85E patients (with second mutation known and not classified as mild) with PS controls (n=44) showed that the G85E patients had a significantly higher sweat chloride, more often failure to thrive at diagnosis, higher prevalence of PI, worse current weight for height, higher prevalence of chronic P. aeruginosa colonisation and liver cirrhosis. Pulse-chase experiments revealed that G85E cystic fibrosis transmembrane conductance regulator failed to mature on a M470 as well as on a V470 background. Therefore, G85E is a class II mutation.

Although there is variability in its clinical presentation, G85E mutation results in a severe phenotype.

This article has been cited by other articles:

				M. Cipolli, C. Castellani, B. Wilcken, J. Massie, K. McKay, M. Gruca, A. Tamanini, M. B. Assael, and K. Gaskin Pancreatic phenotype in infants with cystic fibrosis identified by mutation screening Arch. Dis. Child., October 1, 2007; 92(10): 842 - 846. [Abstract] [Full Text] [PDF]

				K. De Boeck, M. Weren, M. Proesmans, and E. Kerem Pancreatitis Among Patients With Cystic Fibrosis: Correlation With Pancreatic Status and Genotype Pediatrics, April 1, 2005; 115(4): e463 - e469. [Abstract] [Full Text] [PDF]